| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| YUMANITY THERAPEUTICS, INC. | EVP, Head of R&D | Common Stock | 30,000 | $135,000 | $4.50 | 01 Dec 2021 | Direct |
| YUMANITY THERAPEUTICS, INC. | EVP, Head of R&D | Common Stock | 200 | $900 | $4.50 | 01 Dec 2021 | By Spouse |
| YUMANITY THERAPEUTICS, INC. | EVP, Head of R&D | Stock Option (Right to Buy) | 5,000 | 13 Apr 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KANT | YUMANITY THERAPEUTICS, INC. | 01 Dec 2021 | 1 | $0 | 4 | EVP, Head of R&D | 03 Dec 2021, 15:15 |
| KANT | YUMANITY THERAPEUTICS, INC. | 11 Nov 2021 | 1 | $0 | 4 | EVP, Head of R&D | 15 Nov 2021, 07:00 |